CI-1020 is an Orally Active ETA Antagonist for Cardiovascular Disease Research
Chronic hypoxia leads to pulmonary hypertension and pulmonary vascular remodelling in many mammalian species. Hypoxic pulmonary vasoconstriction (HPV) is thought to play a key role in the development of pulmonary…